SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

51,190.24 242.68
(0.48%)

Dow Jones

7,742.36 54.91
(0.71%)

Hang Seng

68,256.51 -700.21
(-1.02%)

Nikkei 225

10,455.36 27.09
(0.26%)

Forex

USD-INR

96.17 0.25
(0.26%)

EUR-INR

108.49 -0.30
(-0.28%)

GBP-INR

127.16 -0.03
(-0.02%)

JPY-INR

0.61 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9539136

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

150.96

100169.98

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.67

Back

Spandana Sphoorty Financial reports consolidated net profit of Rs 11.88 crore in the June 2026 quarter

Jul 24,2026

Net profit of Spandana Sphoorty Financial reported to Rs 11.88 crore in the quarter ended June 2026 as against net loss of Rs 360.21 crore during the previous quarter ended June 2025. Sales declined 5.51% to Rs 283.91 crore in the quarter ended June 2026 as against Rs 300.46 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	283.91	300.46	-6
OPM %	46.81	-108.69	-
PBDT	20.12	-476.65	LP
PBT	17.56	-480.89	LP
NP	11.88	-360.21	LP

71,909.70 -570.59 ( -0.79%)

51,190.24 242.68 (0.48%)

7,742.36 54.91 (0.71%)

68,256.51 -700.21 (-1.02%)

10,455.36 27.09 (0.26%)

96.17 0.25 (0.26%)

108.49 -0.30 (-0.28%)

127.16 -0.03 (-0.02%)

0.61 0.00 (-0.36%)